Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/124891
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMiddeldorp, M.E.-
dc.contributor.authorAriyaratnam, J.-
dc.contributor.authorLau, D.-
dc.contributor.authorSanders, P.-
dc.date.issued2020-
dc.identifier.citationHeart, 2020; 106(5):325-332-
dc.identifier.issn1355-6037-
dc.identifier.issn1468-201X-
dc.identifier.urihttp://hdl.handle.net/2440/124891-
dc.description.abstractThe management of atrial fibrillation (AF) has focused on anticoagulation, rhythm control and ventricular rate control. Recently, a fourth pillar of AF management has been incorporated recognising the importance of risk factor management (RFM). There are several risk factors that contribute to the development and progression of AF, these include traditional risk factors such as age, hypertension, heart failure, diabetes and valvular heart disease. However, increasingly it is recognised that obesity, sleep apnoea, hyperlipidaemia, smoking, alcohol, physical inactivity, genetics, aortic stiffness are associated with the development of AF. Importantly, several of these risk factors are modifiable. We have seen the evolution of RFM programmes which have demonstrated promising results. Indeed, the evidence is now so compelling that major clinical guidelines strongly advocate that aggressive treatment of these risk factors as a key component of AF management. Patients with AF who comprehensively managed their risk factors demonstrate greater reduction in symptoms, AF burden, more successful ablations and improved outcomes with greater AF freedom. In this article, we will review the evidence for the association between cardiac risk factors and AF and assess the burgeoning evidence for improved AF outcomes associated with aggressive cardiac RFM.-
dc.description.statementofresponsibilityMelissa E Middeldorp, Jonathan Ariyaratnam, Dennis Lau, Prashanthan Sanders-
dc.language.isoen-
dc.publisherBMJ Publishing Group-
dc.rights© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.-
dc.source.urihttp://dx.doi.org/10.1136/heartjnl-2019-315327-
dc.subjectHumans-
dc.subjectAtrial Fibrillation-
dc.subjectRisk Factors-
dc.subjectPractice Guidelines as Topic-
dc.subjectHealthy Lifestyle-
dc.titleLifestyle modifications for treatment of atrial fibrillation-
dc.typeJournal article-
dc.identifier.doi10.1136/heartjnl-2019-315327-
dc.relation.grantNHMRC-
pubs.publication-statusPublished-
dc.identifier.orcidMiddeldorp, M.E. [0000-0002-4106-9771]-
dc.identifier.orcidAriyaratnam, J. [0000-0002-8801-8402]-
dc.identifier.orcidLau, D. [0000-0001-7753-1318]-
dc.identifier.orcidSanders, P. [0000-0003-3803-8429]-
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.